logo

Tag: NASDAQ:BTAI

Stock

BioXcel Therapeutics Inc (BTAI) Stock: A Comprehensive 52-Week Review

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. BioXcel Therapeutics Inc’s current trading price is -92.44% away from its 52-week high, while its distance from the 52-week low is -8.58%. The stock’s price

News

BioXcel Therapeutics Inc (BTAI) Stock: A 52-Week Tale of Drops and Gains

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. BioXcel Therapeutics Inc’s current trading price is -90.20% away from its 52-week high, while its distance from the 52-week low

News

BioXcel Therapeutics Inc (BTAI) Stock: A 52-Week Tale of Drops and Gains

Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. BioXcel Therapeutics Inc’s current trading price is -87.79% away from its 52-week high, while its distance from the 52-week low

Stock

BioXcel Therapeutics Inc (BTAI) Stock: A Year of Market Fluctuations

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. BioXcel Therapeutics Inc’s current trading price is -88.08% away from its 52-week high, while its distance from the 52-week low is 32.69%.